Click for best price
Cancer Biomarker Market Size, Share 2024
| Market size in 2023 |
US$ 18470 million
|
Forecast Market size by 2030 |
US$ 41130 million
|
| Growth Rate |
CAGR of 12.0% |
Number of Pages |
146 Pages |
This research report provides a comprehensive analysis of the Cancer Biomarker market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Biomarker market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Biomarker, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Biomarker market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Biomarker market presents opportunities for various stakeholders, including Diagnostics, Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Biomarker market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Biomarker market was valued at US$ 18470 million in 2023 and is projected to reach US$ 41130 million by 2030, at a CAGR of 12.0% during the forecast period.
Key Features:
The research report on the Cancer Biomarker market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Biomarker market.
Market Overview: The report provides a comprehensive overview of the Cancer Biomarker market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Protein Biomarker, Genetic Biomarker), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Biomarker market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Biomarker market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Biomarker market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Biomarker market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Biomarker market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Biomarker market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Biomarker, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Biomarker market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Biomarker market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Protein Biomarker
Genetic Biomarker
Market segment by Application
Diagnostics
Research
Others
Global Cancer Biomarker Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biom?rieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biomarker, market overview.
Chapter 2: Global Cancer Biomarker market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Biomarker capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Biomarker Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 18470 million
|
| Forecast Market size by 2030 |
US$ 41130 million
|
| Growth Rate |
CAGR of 12.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
146 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biomarker Overall Market Size
2.1 Global Cancer Biomarker Market Size: 2023 VS 2030
2.2 Global Cancer Biomarker Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Cancer Biomarker Sales: 2019-2030
3 Company Landscape
3.1 Top Cancer Biomarker Players in Global Market
3.2 Top Global Cancer Biomarker Companies Ranked by Revenue
3.3 Global Cancer Biomarker Revenue by Companies
3.4 Global Cancer Biomarker Sales by Companies
3.5 Global Cancer Biomarker Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Cancer Biomarker Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Cancer Biomarker Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Biomarker Players in Global Market
3.8.1 List of Global Tier 1 Cancer Biomarker Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Biomarker Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biomarker Market Size Markets, 2023 & 2030
4.1.2 Protein Biomarker
4.1.3 Genetic Biomarker
4.2 By Type - Global Cancer Biomarker Revenue & Forecasts
4.2.1 By Type - Global Cancer Biomarker Revenue, 2019-2024
4.2.2 By Type - Global Cancer Biomarker Revenue, 2025-2030
4.2.3 By Type - Global Cancer Biomarker Revenue Market Share, 2019-2030
4.3 By Type - Global Cancer Biomarker Sales & Forecasts
4.3.1 By Type - Global Cancer Biomarker Sales, 2019-2024
4.3.2 By Type - Global Cancer Biomarker Sales, 2025-2030
4.3.3 By Type - Global Cancer Biomarker Sales Market Share, 2019-2030
4.4 By Type - Global Cancer Biomarker Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biomarker Market Size, 2023 & 2030
5.1.2 Diagnostics
5.1.3 Research
5.1.4 Others
5.2 By Application - Global Cancer Biomarker Revenue & Forecasts
5.2.1 By Application - Global Cancer Biomarker Revenue, 2019-2024
5.2.2 By Application - Global Cancer Biomarker Revenue, 2025-2030
5.2.3 By Application - Global Cancer Biomarker Revenue Market Share, 2019-2030
5.3 By Application - Global Cancer Biomarker Sales & Forecasts
5.3.1 By Application - Global Cancer Biomarker Sales, 2019-2024
5.3.2 By Application - Global Cancer Biomarker Sales, 2025-2030
5.3.3 By Application - Global Cancer Biomarker Sales Market Share, 2019-2030
5.4 By Application - Global Cancer Biomarker Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Biomarker Market Size, 2023 & 2030
6.2 By Region - Global Cancer Biomarker Revenue & Forecasts
6.2.1 By Region - Global Cancer Biomarker Revenue, 2019-2024
6.2.2 By Region - Global Cancer Biomarker Revenue, 2025-2030
6.2.3 By Region - Global Cancer Biomarker Revenue Market Share, 2019-2030
6.3 By Region - Global Cancer Biomarker Sales & Forecasts
6.3.1 By Region - Global Cancer Biomarker Sales, 2019-2024
6.3.2 By Region - Global Cancer Biomarker Sales, 2025-2030
6.3.3 By Region - Global Cancer Biomarker Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Cancer Biomarker Revenue, 2019-2030
6.4.2 By Country - North America Cancer Biomarker Sales, 2019-2030
6.4.3 US Cancer Biomarker Market Size, 2019-2030
6.4.4 Canada Cancer Biomarker Market Size, 2019-2030
6.4.5 Mexico Cancer Biomarker Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Cancer Biomarker Revenue, 2019-2030
6.5.2 By Country - Europe Cancer Biomarker Sales, 2019-2030
6.5.3 Germany Cancer Biomarker Market Size, 2019-2030
6.5.4 France Cancer Biomarker Market Size, 2019-2030
6.5.5 U.K. Cancer Biomarker Market Size, 2019-2030
6.5.6 Italy Cancer Biomarker Market Size, 2019-2030
6.5.7 Russia Cancer Biomarker Market Size, 2019-2030
6.5.8 Nordic Countries Cancer Biomarker Market Size, 2019-2030
6.5.9 Benelux Cancer Biomarker Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Cancer Biomarker Revenue, 2019-2030
6.6.2 By Region - Asia Cancer Biomarker Sales, 2019-2030
6.6.3 China Cancer Biomarker Market Size, 2019-2030
6.6.4 Japan Cancer Biomarker Market Size, 2019-2030
6.6.5 South Korea Cancer Biomarker Market Size, 2019-2030
6.6.6 Southeast Asia Cancer Biomarker Market Size, 2019-2030
6.6.7 India Cancer Biomarker Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Cancer Biomarker Revenue, 2019-2030
6.7.2 By Country - South America Cancer Biomarker Sales, 2019-2030
6.7.3 Brazil Cancer Biomarker Market Size, 2019-2030
6.7.4 Argentina Cancer Biomarker Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Biomarker Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Cancer Biomarker Sales, 2019-2030
6.8.3 Turkey Cancer Biomarker Market Size, 2019-2030
6.8.4 Israel Cancer Biomarker Market Size, 2019-2030
6.8.5 Saudi Arabia Cancer Biomarker Market Size, 2019-2030
6.8.6 UAE Cancer Biomarker Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cancer Biomarker Major Product Offerings
7.1.4 Thermo Fisher Scientific Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Summary
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories Cancer Biomarker Major Product Offerings
7.2.4 Bio-Rad Laboratories Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.2.5 Bio-Rad Laboratories Key News & Latest Developments
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Summary
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Cancer Biomarker Major Product Offerings
7.3.4 Roche Diagnostics Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.3.5 Roche Diagnostics Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Cancer Biomarker Major Product Offerings
7.4.4 Qiagen Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.4.5 Qiagen Key News & Latest Developments
7.5 Illumina
7.5.1 Illumina Company Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina Cancer Biomarker Major Product Offerings
7.5.4 Illumina Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.5.5 Illumina Key News & Latest Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Company Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Cancer Biomarker Major Product Offerings
7.6.4 GE Healthcare Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.6.5 GE Healthcare Key News & Latest Developments
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Summary
7.7.2 Agilent Technologies Business Overview
7.7.3 Agilent Technologies Cancer Biomarker Major Product Offerings
7.7.4 Agilent Technologies Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.7.5 Agilent Technologies Key News & Latest Developments
7.8 Biom?rieux SA
7.8.1 Biom?rieux SA Company Summary
7.8.2 Biom?rieux SA Business Overview
7.8.3 Biom?rieux SA Cancer Biomarker Major Product Offerings
7.8.4 Biom?rieux SA Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.8.5 Biom?rieux SA Key News & Latest Developments
7.9 Merck & Co.
7.9.1 Merck & Co. Company Summary
7.9.2 Merck & Co. Business Overview
7.9.3 Merck & Co. Cancer Biomarker Major Product Offerings
7.9.4 Merck & Co. Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.9.5 Merck & Co. Key News & Latest Developments
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Summary
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Cancer Biomarker Major Product Offerings
7.10.4 Abbott Laboratories Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.10.5 Abbott Laboratories Key News & Latest Developments
7.11 Becton, Dickinson and Company
7.11.1 Becton, Dickinson and Company Company Summary
7.11.2 Becton, Dickinson and Company Business Overview
7.11.3 Becton, Dickinson and Company Cancer Biomarker Major Product Offerings
7.11.4 Becton, Dickinson and Company Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.11.5 Becton, Dickinson and Company Key News & Latest Developments
7.12 Danaher Corporation
7.12.1 Danaher Corporation Company Summary
7.12.2 Danaher Corporation Business Overview
7.12.3 Danaher Corporation Cancer Biomarker Major Product Offerings
7.12.4 Danaher Corporation Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.12.5 Danaher Corporation Key News & Latest Developments
7.13 Myriad Genetics
7.13.1 Myriad Genetics Company Summary
7.13.2 Myriad Genetics Business Overview
7.13.3 Myriad Genetics Cancer Biomarker Major Product Offerings
7.13.4 Myriad Genetics Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.13.5 Myriad Genetics Key News & Latest Developments
7.14 Sysmex Corporation
7.14.1 Sysmex Corporation Company Summary
7.14.2 Sysmex Corporation Business Overview
7.14.3 Sysmex Corporation Cancer Biomarker Major Product Offerings
7.14.4 Sysmex Corporation Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.14.5 Sysmex Corporation Key News & Latest Developments
7.15 Hologic
7.15.1 Hologic Company Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Cancer Biomarker Major Product Offerings
7.15.4 Hologic Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.15.5 Hologic Key News & Latest Developments
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Company Summary
7.16.2 Quest Diagnostics Business Overview
7.16.3 Quest Diagnostics Cancer Biomarker Major Product Offerings
7.16.4 Quest Diagnostics Cancer Biomarker Sales and Revenue in Global (2019-2024)
7.16.5 Quest Diagnostics Key News & Latest Developments
8 Global Cancer Biomarker Production Capacity, Analysis
8.1 Global Cancer Biomarker Production Capacity, 2019-2030
8.2 Cancer Biomarker Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Biomarker Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Biomarker Supply Chain Analysis
10.1 Cancer Biomarker Industry Value Chain
10.2 Cancer Biomarker Upstream Market
10.3 Cancer Biomarker Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Biomarker Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cancer Biomarker in Global Market
Table 2. Top Cancer Biomarker Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Cancer Biomarker Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Cancer Biomarker Revenue Share by Companies, 2019-2024
Table 5. Global Cancer Biomarker Sales by Companies, (K Units), 2019-2024
Table 6. Global Cancer Biomarker Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Cancer Biomarker Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Cancer Biomarker Product Type
Table 9. List of Global Tier 1 Cancer Biomarker Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biomarker Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Cancer Biomarker Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Cancer Biomarker Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Cancer Biomarker Sales (K Units), 2019-2024
Table 15. By Type - Global Cancer Biomarker Sales (K Units), 2025-2030
Table 16. By Application ? Global Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Cancer Biomarker Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Cancer Biomarker Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Cancer Biomarker Sales (K Units), 2019-2024
Table 20. By Application - Global Cancer Biomarker Sales (K Units), 2025-2030
Table 21. By Region ? Global Cancer Biomarker Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Cancer Biomarker Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Cancer Biomarker Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Cancer Biomarker Sales (K Units), 2019-2024
Table 25. By Region - Global Cancer Biomarker Sales (K Units), 2025-2030
Table 26. By Country - North America Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Cancer Biomarker Sales, (K Units), 2019-2024
Table 29. By Country - North America Cancer Biomarker Sales, (K Units), 2025-2030
Table 30. By Country - Europe Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Cancer Biomarker Sales, (K Units), 2019-2024
Table 33. By Country - Europe Cancer Biomarker Sales, (K Units), 2025-2030
Table 34. By Region - Asia Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Cancer Biomarker Sales, (K Units), 2019-2024
Table 37. By Region - Asia Cancer Biomarker Sales, (K Units), 2025-2030
Table 38. By Country - South America Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Cancer Biomarker Sales, (K Units), 2019-2024
Table 41. By Country - South America Cancer Biomarker Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Cancer Biomarker Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Cancer Biomarker Sales, (K Units), 2025-2030
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific Cancer Biomarker Product Offerings
Table 48. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Bio-Rad Laboratories Company Summary
Table 51. Bio-Rad Laboratories Cancer Biomarker Product Offerings
Table 52. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Bio-Rad Laboratories Key News & Latest Developments
Table 54. Roche Diagnostics Company Summary
Table 55. Roche Diagnostics Cancer Biomarker Product Offerings
Table 56. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Roche Diagnostics Key News & Latest Developments
Table 58. Qiagen Company Summary
Table 59. Qiagen Cancer Biomarker Product Offerings
Table 60. Qiagen Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Qiagen Key News & Latest Developments
Table 62. Illumina Company Summary
Table 63. Illumina Cancer Biomarker Product Offerings
Table 64. Illumina Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Illumina Key News & Latest Developments
Table 66. GE Healthcare Company Summary
Table 67. GE Healthcare Cancer Biomarker Product Offerings
Table 68. GE Healthcare Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. GE Healthcare Key News & Latest Developments
Table 70. Agilent Technologies Company Summary
Table 71. Agilent Technologies Cancer Biomarker Product Offerings
Table 72. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Agilent Technologies Key News & Latest Developments
Table 74. Biom?rieux SA Company Summary
Table 75. Biom?rieux SA Cancer Biomarker Product Offerings
Table 76. Biom?rieux SA Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Biom?rieux SA Key News & Latest Developments
Table 78. Merck & Co. Company Summary
Table 79. Merck & Co. Cancer Biomarker Product Offerings
Table 80. Merck & Co. Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Merck & Co. Key News & Latest Developments
Table 82. Abbott Laboratories Company Summary
Table 83. Abbott Laboratories Cancer Biomarker Product Offerings
Table 84. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Abbott Laboratories Key News & Latest Developments
Table 86. Becton, Dickinson and Company Company Summary
Table 87. Becton, Dickinson and Company Cancer Biomarker Product Offerings
Table 88. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Becton, Dickinson and Company Key News & Latest Developments
Table 90. Danaher Corporation Company Summary
Table 91. Danaher Corporation Cancer Biomarker Product Offerings
Table 92. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Danaher Corporation Key News & Latest Developments
Table 94. Myriad Genetics Company Summary
Table 95. Myriad Genetics Cancer Biomarker Product Offerings
Table 96. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Myriad Genetics Key News & Latest Developments
Table 98. Sysmex Corporation Company Summary
Table 99. Sysmex Corporation Cancer Biomarker Product Offerings
Table 100. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. Sysmex Corporation Key News & Latest Developments
Table 102. Hologic Company Summary
Table 103. Hologic Cancer Biomarker Product Offerings
Table 104. Hologic Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 105. Hologic Key News & Latest Developments
Table 106. Quest Diagnostics Company Summary
Table 107. Quest Diagnostics Cancer Biomarker Product Offerings
Table 108. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 109. Quest Diagnostics Key News & Latest Developments
Table 110. Cancer Biomarker Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 111. Global Cancer Biomarker Capacity Market Share of Key Manufacturers, 2022-2024
Table 112. Global Cancer Biomarker Production by Region, 2019-2024 (K Units)
Table 113. Global Cancer Biomarker Production by Region, 2025-2030 (K Units)
Table 114. Cancer Biomarker Market Opportunities & Trends in Global Market
Table 115. Cancer Biomarker Market Drivers in Global Market
Table 116. Cancer Biomarker Market Restraints in Global Market
Table 117. Cancer Biomarker Raw Materials
Table 118. Cancer Biomarker Raw Materials Suppliers in Global Market
Table 119. Typical Cancer Biomarker Downstream
Table 120. Cancer Biomarker Downstream Clients in Global Market
Table 121. Cancer Biomarker Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Biomarker Segment by Type in 2023
Figure 2. Cancer Biomarker Segment by Application in 2023
Figure 3. Global Cancer Biomarker Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Biomarker Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Biomarker Revenue, 2019-2030 (US$, Mn)
Figure 7. Cancer Biomarker Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Biomarker Revenue in 2023
Figure 9. By Type - Global Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Cancer Biomarker Revenue Market Share, 2019-2030
Figure 11. By Type - Global Cancer Biomarker Sales Market Share, 2019-2030
Figure 12. By Type - Global Cancer Biomarker Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Cancer Biomarker Revenue Market Share, 2019-2030
Figure 15. By Application - Global Cancer Biomarker Sales Market Share, 2019-2030
Figure 16. By Application - Global Cancer Biomarker Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Cancer Biomarker Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Cancer Biomarker Revenue Market Share, 2019-2030
Figure 20. By Region - Global Cancer Biomarker Sales Market Share, 2019-2030
Figure 21. By Country - North America Cancer Biomarker Revenue Market Share, 2019-2030
Figure 22. By Country - North America Cancer Biomarker Sales Market Share, 2019-2030
Figure 23. US Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Cancer Biomarker Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Cancer Biomarker Sales Market Share, 2019-2030
Figure 28. Germany Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 29. France Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Cancer Biomarker Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Cancer Biomarker Sales Market Share, 2019-2030
Figure 37. China Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 41. India Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Cancer Biomarker Revenue Market Share, 2019-2030
Figure 43. By Country - South America Cancer Biomarker Sales Market Share, 2019-2030
Figure 44. Brazil Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Cancer Biomarker Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Cancer Biomarker Sales Market Share, 2019-2030
Figure 48. Turkey Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 52. Global Cancer Biomarker Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Cancer Biomarker by Region, 2023 VS 2030
Figure 54. Cancer Biomarker Industry Value Chain
Figure 55. Marketing Channels
